Search

D-serine is present in the mammalian central nervous system, where it acts as one of the co-activators of N-methyl-D aspartate receptors. Synthesis of D-serine is catalyzed by the serine racemase enzyme. The current studies report on the isolation of a cDNA encoding a human serine racemase (SRR) from the human neuronal like cell line, NT2N. The SRR gene was localized on chromosome 17q13. The full-length cDNA has 1020 nucleotides which encode for a protein of 340 amino acids. The human protein shares 89% sequence identity with the mouse serine racemase. Human embryonic kidney 293 cells transiently transfected with this SRR gene were able to produce d-serine, indicating that the sequence encodes for an active enzyme. In Northern blot analysis the SRR mRNA was expressed in human brain, heart, skeletal muscle, kidney and liver tissues. Different splice forms of SRR were present in the peripheral tissues. Transcripts of at least three different sizes were present in heart and kidney, while in Western blot analysis multiple bands of different sizes were observed. Immunohistochemical studies, using a polyclonal anti-human serine racemase antibody, revealed a peripheral expression of serine racemase protein in human cardiac myocytes and convoluted tubules of the kidney. Experiments in non-human primate brain demonstrated the localization of SRR in amygdala nuclei, cortex, thalamus and hippocampus. Co-localization studies in the hippocampus demonstrated the exclusive expression of serine racemase in glial cells. The cloning of a functional human serine racemase and its expression in central nervous system of primates support a role for D-serine in neuronal activity. Furthermore, its presence in human periphery such as in heart and kidney suggest a potential biological role for D-serine in the regulation of N-methyl-D-aspartate (NMDA) receptor activity in these peripheral organs as well.

The distribution of the GABAA receptor in the goldfish brainstem and on the Mauthner cell membrane was investigated with both optical and electron microscopy using a polyclonal antibody raised against the intracellular loop of the rat gamma 2 subunit. At the optical level, immunofluorescent dots were detected on small and large neurons belonging to vestibular and reticular nuclei. On the Mauthner cell plasmalemma, a gamma 2-like immunoreactivity was observed predominantly on the tip of the lateral dendrite. Fluorescent parches were intermingled with a more diffuse staining. Immunoreactive spots of weaker intensity were also present on the soma and some were also observed inside and within the periphery of the axon-cap as well. Observations at the electron microscopic level revealed that the peroxidase end-product predominates postsynaptically in front of release sites in the studied nuclei and on the Mauthner cell. On the lateral dendrite of the neuron, numerous immunopositive postsynaptic differentiations were encountered on spines. Stained glial elements were encountered in the different areas studied. These results demonstrate that the GABAA receptor gamma 2 subunit has a precise distribution on neuronal membranes and suggest that it could be involved in the remote dendritic inhibition of the Mauthner cell and in the control of input-output properties of both vestibular and reticular nuclei.

Synapses are complex arrangements of pre- and postsynaptic differentiations involved in neural communication. A key element in this synaptic transmission is the presynaptic active zone where the release of neurotransmitter occurs. Active zones can be visualized and analyzed after staining with ethanolic phosphotungstic acid (EPTA) on semithin (0.5 micron) sections. This staining has been used in association with postembedding immunogold labeling for the neurotransmitters glycine or GABA, to investigate the organization of chemically defined inhibitory active zones, viewed in their full extent, on different regions of the goldfish Mauthner (M-) cell. With this approach, a marked variability in size and shape was observed for the release sites contacting the different parts of the postsynaptic neuron. In the axon cap and on the soma, glycinergic afferent terminals have small presynaptic grids (0.066 +/- 0.029 micron2, n = 30 and 0.076 +/- 0.037 micron2, n = 46, respectively). These grids are quite circular and they include 12 to 13 presynaptic dense projections (PDPs). The situation is different on the lateral dendrite, where glycinergic and GABAergic active zones display a greater variability in their surface areas (mean = 0.147 +/- 0.100 micron2, n = 115 and 0.139 +/- 0.080 micron2, n = 125, respectively), and their number of PDPs (mean = 19 +/- 9) per individual grid. Similarly, the shape of the release sites over the dendrite is more complex (annular, horseshoe-shaped) when compared to those on the soma. These differences of dendritic versus somatic release sites could represent a structural basis to maximize the shunting effect of glycinergic and GABAergic inhibitory junctions, i.e., close to excitatory inputs. We also observed that the proportion of endings containing 1 or more active zones also varies. More precisely, 96% and 82% of glycinergic terminals in the axon cap and on the soma, respectively, display only one active zone. On the dendrite, their proportion falls to 65.5% for both glycine- and GABA-containing boutons. The remaining inhibitory terminals contain 2 (30%) and 3 to 4 (4.5%) presynaptic grids. These results reveal a greater variability of morphology and organization of the inhibitory release sites at dendritic versus somatic locations. The functional significance of this observation for the synaptic transmission is discussed.

Glycine is a major inhibitory neurotransmitter in the spinal cord and in the brain stem, where it acts by activating a chloride conductance. The postsynaptic glycine receptor has been purified and contains two transmembrane subunits of 48 kDa (alpha) and 58 kDa (beta), and a peripheral membrane protein of 93 kDa. cDNA sequencing of the alpha and beta subunits has revealed a common structural organization and a strong homology between these polypeptides and the nicotinic acetylcholine and GABAA receptor proteins. The glycine receptor exhibits a heterogeneity resulting from the existence of several alpha subtypes with distinct functional properties and different developmental expressions. When present in the central nervous system in situ, as well as in primary cultures of spinal cord neurons, these receptors are localized at the postsynaptic membrane adjacent to the presynaptic release sites, thus forming functional microdomains at the neuronal surface. This distribution raises the question of the formation and the maintenance of the heterogeneity of the somato-dendritic plasma membrane.

The presence of somatostatin in afferent fibers impinging on the goldfish Mauthner (M-) cell was determined using immunohistochemical methods, combined with confocal and electron microscopy, and the relationship of this peptide with inhibitory and excitatory terminals was studied. Somatostatin-reactive boutons were present only on the distal part of the M-cell's lateral dendrite. Somatostatin immunoreactivity was observed in typical large myelinated club endings (LMCEs) corresponding to mixed (electrical and chemical) eighth nerve primary afferent fibers. The axoplasm of these fibers contained dense-core vesicles (DCVs) dispersed among round vesicles. We have made a novel finding that the excitatory transmitter glutamate is present in LMCEs. Colocalization of this amino acid with somatostatin was detected in 75% of these endings using postembedding staining with gold particles of various sizes. The other structures labeled by somatostatin antibody were found to be small vesicle boutons (SVBs), which establish symmetrical synapses and contain a population of pleiomorphic vesicles with DCVs scattered among them. Double labeling with antibodies against glutamic acid decarboxylase and GABA allowed the definition of three types of biochemically characterized terminals: [somatostatin-GABA], [GABA], and [somatostatin]. However, the occurrence of DCVs in SVBs stained for GABA alone suggests that neuropeptides other than somatostatin may also coexist with GABA in this class of boutons. The coexistence of somatostatin with both inhibitory and excitatory neurotransmitters acting on the same region of a postsynaptic cell is discussed in relation to the role postulated for this peptide in synaptic plasticity.

Immunocytochemical methods were used on serial sections to study the glycine- and gamma-amino butyric acid (GABA)ergic innervations of the teleost Mauthner (M) cell. We found different distributions for the boutons containing the two amino acids. Endings filled with GABA predominate on the distal portion of the lateral dendrite (LD) while glycine-positive profiles are more abundant on the soma and within the axon cap (AC), a specialized neuropil surrounding the M-cell initial segment. A few endings containing both transmitters are present on the soma and on the small dendrites issuing ventrally from it. At this level some glutamic acid decarboxylase (GAD)-containing boutons face glycine receptor-93 kD-associated protein, an observation suggesting that the associated glycine functions as a neurotransmitter. Elsewhere on the M-cell, where glycine and GABA are not colocalized, GAD-positive profiles were never observed in front of postsynaptic differentiations with 93 kD labelling. GABA was detected in the small vesicle boutons (SVBs), most of them, following the classification of Tuttle et al., J. Comp. Neurol. 265:254-274, 1987, belonging to the A-type, while glycine was found in the unmyelinated club endings in the AC, and in C- and B-type SVBs, outside this region. All terminals established symmetrical synapses and were filled with a population of pleiomorphic vesicles. Boutons with GABA also contained numerous dense-core vesicles suggesting the presence of an associated peptide(s). A quantitative study of the transmitter content based on the number of the gold particles revealed a variable intensity of the labelling over certain profiles. For GABA, it was maximum at the tip of the LD and it decreased proximally. In contrast, the staining density was constant for glycine along all parts of the cell, except for the ventral dendrite (VD) where it decreased progressively. Taken together, these data suggest that the amino acid content varies, depending upon the location of the synapses on their target neuron.